Elite Pharmaceuticals, Inc. Income Taxes Paid
Elite Pharmaceuticals, Inc. (ELTP) reported Income Taxes Paid of $19.55 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-13
- Elite Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2026-06-30 was $19.55K.
- Elite Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2026-03-31 was $127.53K.
- Elite Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2025-12-31 was $227.15K, a 6.90% decline year-over-year.
- Elite Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2025-03-31 was -$128.18K.
- Elite Pharmaceuticals, Inc. income taxes paid, net for fiscal 2026 was $1.15M, a 88.01% increase from fiscal 2025.
- Elite Pharmaceuticals, Inc. income taxes paid, net for fiscal 2025 was $612.09K, a 109.62% increase from fiscal 2024.
- Elite Pharmaceuticals, Inc. income taxes paid, net for fiscal 2024 was $292.00K, a 31.14% decline from fiscal 2023.
- Elite Pharmaceuticals, Inc. income taxes paid, net for fiscal 2023 was $424.03K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.55K 10-Q · filed 2026-08-13 | $147.08K derived: sum of 2 quarters · filed 2026-08-13 | $374.23K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2026-03-31 | $127.53K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $354.68K derived: sum of 2 quarters · filed 2026-06-29 | $1.15M 10-K · filed 2026-06-29 | |
| 2025-12-31 | $227.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | $1.02M 10-Q · filed 2026-02-17 | ||
| 2025-09-30 | $796.10K 10-Q · filed 2025-11-14 | |||
| 2025-03-31 | -$128.18K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $115.82K derived: sum of 2 quarters · filed 2026-06-29 | $612.09K 10-K · filed 2026-06-29 | |
| 2024-12-31 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | $740.26K 10-Q · filed 2026-02-17 | ||
| 2024-09-30 | $496.26K 10-Q · filed 2025-11-14 | |||
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-30 | $164.48K derived: sum of 2 quarters · filed 2025-06-30 | $164.48K derived: sum of 3 quarters · filed 2025-06-30 | $292.00K 10-K · filed 2025-06-30 |
| 2023-12-31 | $164.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $164.48K derived: sum of 2 quarters · filed 2025-02-13 | $292.00K 10-Q · filed 2025-02-13 | $588.51K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-14 | $127.52K 10-Q · filed 2024-11-14 | $424.03K derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-06-30 | $127.52K 10-Q · filed 2024-08-14 | $424.03K derived: sum of 2 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $296.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-01 | $424.03K 10-K · filed 2024-07-01 | ||
| 2022-12-31 | $127.52K 10-Q · filed 2024-02-14 | |||
| 2018-03-31 | $5.50K 10-K · filed 2019-06-21 |